Abstract INTRODUCTION Crohn’s disease (CD) is a complex disease, and assessing activity is challenging due to pathobiologic process e.g. ECM remodeling, mucosal damage, and intestinal fibrosis, which greatly limits current disease activity assessments through e.g. endoscopy and imaging techniques. AREAS COVERED The review highlights the importance of novel biomarkers reflecting ECM remodeling and immune cell […]
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease.
June 1, 2023
Expert Rev Gastroenterol Hepatol